Efficacy of Albumin Interferon Alfa-2b With Ribavirin Compared to Peg-IFN Alfa-2a With Ribavirin in IFN Naive Patients Geno2/3
Study Details
Study Description
Brief Summary
This is a phase 3, randomized, multi-center study to evaluate the efficacy and safety of albumin interferon alfa-2b (alb-IFN)in combination with ribavirin compared with peginterferon alfa-2a (PEGASYS or PEG-IFNa2a) in combination with ribavirin in subjects with chronic hepatitis C, genotype 2/3 who are IFNa treatment naive.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Phase 3 |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: 1 900 mcg alb-IFN every 2 weeks (12 doses) + Ribavirin 800 micrograms per day |
Drug: albumin interferon alfa-2b
900 and 1200 micrograms Albumin Interferon Alpha 2a given subcutaneously once every two weeks for 24 weeks
Drug: Ribavirin
800mg/day for 24 weeks
|
Experimental: 2 1200 mcg alb-IFN every 2 weeks (12 doses) + Ribavirin 800 micrograms per day |
Drug: albumin interferon alfa-2b
900 and 1200 micrograms Albumin Interferon Alpha 2a given subcutaneously once every two weeks for 24 weeks
Drug: Ribavirin
800mg/day for 24 weeks
|
Active Comparator: 3 180 mcg PEG-IFNx2a every 1 week (24 doses)+ Ribavirin 800 micrograms per day |
Drug: peginterferon alfa-2a
180 micrograms Pegasys given subcutaneaously once a week for 24 weeks
Drug: Ribavirin
800mg/day for 24 weeks
|
Outcome Measures
Primary Outcome Measures
- Sustained virologic response (SVR) [Week 48]
Secondary Outcome Measures
- Rapid virologic response [Week 4]
- Early virologic response [Week 12]
- Undetectable HCV RNA [Week 24]
- Normalization of ALT (a liver enzyme) [Week 48]
- Quality of life evaluation [Week 48]
- Safety assessments (physical exams, Ae reporting, lab testing/analysis, HADS and Immunogenicity results) [Througout the entire treatment period]
Eligibility Criteria
Criteria
Key Inclusion Criteria:
-
Diagnosis of chronic hepatitis C.
-
Liver biopsy performed within 2 years of Day 0 or during screening.
-
Infected with hepatitis C virus genotype 2/3.
-
Interferon alfa treatment naïve (ie, have never been treated with an interferon product).
-
Subjects are eligible to enter the study if they (or their partners) are not pregnant or nursing, are sterile, or of non childbearing potential, or are willing to practice abstinence or use appropriate birth control methods during the study and for 7 months after the last dose of ribavirin.
-
Have compensated liver disease.
Key Exclusion Criteria:
-
Decompensated liver disease including those subjects with a past history or presence of ascites, bleeding varices or hepatic encephalopathy.
-
History of moderate, severe or uncontrolled psychiatric disease, especially depression, including a history of hospitalization or prior suicidal attempt.
-
Positive for human immunodeficiency virus (HIV-1) or hepatitis B surface antigen (HBsAG).
-
Clinical diagnosis of other causes of chronic liver disease including but not limited to hepatitis B, autoimmune hepatitis, primary biliary cirrhosis, alcoholic liver disease, hemochromatosis, Wilson's Disease, or alpha 1-antitrypsin deficiency.
-
A history of immunologically mediated disease (eg, rheumatoid arthritis, inflammatory bowel disease, moderate/severe psoriasis, sarcoidosis, systemic lupus erythematosus).
-
Active seizure disorder within the last 2 years.
-
Organ transplant other than cornea and hair transplant.
-
Clinically significant hemoglobinopathy (eg, thalassemia, sickle cell anemia).
-
Cancer within the last 5 years(with the exception of adequately treated basal cell carcinoma of the skin or in situ carcinoma of the uterine cervix).
-
Drug or alcohol addiction within the last 6 months. Subjects in a supervised methadone treatment program may be enrolled in the study.
-
Received any experimental agent within 28 days prior to Day 0.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Mayo Clinic Hospital | Phoenix | Arizona | United States | 85054 |
2 | Scripps Clinic | La Jolla | California | United States | 92037 |
3 | California Pacific Medical Center | San Francisco | California | United States | 94115 |
4 | University of Colorado | Denver | Colorado | United States | 80262-0001 |
5 | University of Florida-Gainesville | Gainesville | Florida | United States | 32610 |
6 | Shands Jacksonville Medical Center | Jacksonville | Florida | United States | 32209 |
7 | Mayo Clinic Transplant Center | Jacksonville | Florida | United States | 32216 |
8 | University of Miami | Miami | Florida | United States | 33136-1051 |
9 | Atlanta Gastroenterology Associates | Atlanta | Georgia | United States | 30308 |
10 | GI of Atlanta | Atlanta | Georgia | United States | 30309 |
11 | University of Chicago Hospital | Chicago | Illinois | United States | 60637 |
12 | Johns Hopkins Center for Viral Hepatits | Baltimore | Maryland | United States | 21287 |
13 | Beth Israel Deaconess Medical Center | Boston | Massachusetts | United States | 02215 |
14 | Minnesota Gastroenterology, P.A. | Plymouth | Minnesota | United States | 55446 |
15 | Dartmouth Hitchcock Medical Center | Lebanon | New Hampshire | United States | 03756 |
16 | University of New Mexico | Albuquerque | New Mexico | United States | 87131-0001 |
17 | Bronx VA Medical Center | Bronx | New York | United States | 10468 |
18 | New York Hospital - Cornell | New York | New York | United States | 10021 |
19 | Faculty Practice Associates | New York | New York | United States | 10029 |
20 | NY Presbyterian Medical Center - Columbia Univ. Med Center | New York | New York | United States | 10032 |
21 | University of North Carolina at Chapel Hill | Chapel Hill | North Carolina | United States | 27599-7584 |
22 | Regional Gastroenterology Associates of Lancaster, Ltd. | Lancaster | Pennsylvania | United States | 17604-3200 |
23 | Thomas Jefferson University | Philadelphia | Pennsylvania | United States | 19107 |
24 | Temple University Hospital | Philadelphia | Pennsylvania | United States | 19140 |
25 | Baylor University Medical Center | Dallas | Texas | United States | 75246 |
26 | Brooke Army Medical Center | Fort Sam Houston | Texas | United States | 78234 |
27 | Alamo Medrical Research | San Antonio | Texas | United States | 78215 |
28 | Metropolitan Research | Fairfax | Virginia | United States | 22031 |
29 | Unidad de Hepatología | Capital Federal | Buenos Aires | Argentina | C1093AAS |
30 | Fundación Cidea | Capital Federal | Buenos Aires | Argentina | C1121ABE |
31 | Hospital Italiano | Capital Federal | Buenos Aires | Argentina | C1181ACH |
32 | Hospital Universitario Austral | Pilar | Buenos Aires | Argentina | B1629AHJ |
33 | Htal Pcial del Centenario | Rosario | Santa Fe | Argentina | 2000 |
34 | Royal Prince Alfred Hospital | Camperdown | New South Wales | Australia | 2050 |
35 | Concord Repatriation General Hospital | Concord | New South Wales | Australia | 2139 |
36 | St George Hospital Clinical School of Medicine | Kogarah | New South Wales | Australia | 2217 |
37 | John Hunter Hospital | New Lambton | New South Wales | Australia | 2305 |
38 | Westmead Hospital | Westmead | New South Wales | Australia | 2145 |
39 | Gallipoli Research Foundation and Greenslopes Private Hospital | Greenslopes | Queensland | Australia | 4120 |
40 | Royal Bribane & Women's Hospital | Herston | Queensland | Australia | 4029 |
41 | Royal Adelaide Hospital | Adelaide | South Australia | Australia | 5000 |
42 | Monash Medical Centre | Clayton | Victoria | Australia | 3168 |
43 | St Vincent's Hospital | Fitzroy, Victoria | Victoria | Australia | 3065 |
44 | Western Hospital | Footscray | Victoria | Australia | 3011 |
45 | Austin Hospital | Heidelburg | Victoria | Australia | 3081 |
46 | The Alfred Hospital | Melbourne | Victoria | Australia | 3004 |
47 | Royal Melbourne Hospital | Parkville | Victoria | Australia | 3050 |
48 | Fremantle Hospital | Fremantle | Western Australia | Australia | 6160 |
49 | CHU Brugmann ULB - site Victor Horta | Brussels | Belgium | 1020 | |
50 | UCL | Brussels | Belgium | 1200 | |
51 | University Hospital Antwerp | Edegem | Belgium | 2650 | |
52 | Ghent University Hospital | Gent | Belgium | 9000 | |
53 | CHU Sart Tilman | Liège | Belgium | 4000 | |
54 | Hospital Universitário Professor Edgard Santos - Universidade Federal da Bahia | Salvador | BA | Brazil | 40110-170 |
55 | Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo | Ribeirão Preto | SP | Brazil | 14049-900 |
56 | Universidade Federal de São Paulo - UNIFESP | São Paulo | SP | Brazil | 04023-900 |
57 | Hospital Heliópolis | São Paulo | SP | Brazil | 04230-000 |
58 | Hospital das Clínicas da Faculdade de Medicina da USP | São Paulo | SP | Brazil | 05403-000 |
59 | Heritage Medical Research Clinic | Calgary | Alberta | Canada | T2N 4N1 |
60 | University of Alberta | Edmonton | Alberta | Canada | T5H 4B9 |
61 | University of Alberta Hospital | Edmonton | Alberta | Canada | T6G 2X8 |
62 | Vancouver General Hospital | Vancouver | British Columbia | Canada | V5Z 3P1 |
63 | University of Manitoba Health Sciences Centre | Winnipeg | Manitoba | Canada | R3E 3P4 |
64 | University of Western Ontario Hospital | London | Ontario | Canada | N6A 5A5 |
65 | Ottawa Hospital - General Campus | Ottawa | Ontario | Canada | K1H 8L6 |
66 | Toronto General Hospital | Toronto | Ontario | Canada | M5G 2N2 |
67 | Toronto Western Hospital | Toronto | Ontario | Canada | M5T 2S8 |
68 | McGill University | Montreal | Quebec | Canada | H3A 1A1 |
69 | Hopital Beaujon | Clichy | France | 92110 | |
70 | Hopital Henri Mondor | Creteil | France | 94010 | |
71 | CHU de Lyon, Hôpital de l'Hôtel Dieu | Lyon Cedex 02 | France | 69288 | |
72 | Hopital Saint-Joseph | Marseille Cedex 08 | France | 13285 | |
73 | Hopital de La Source | Orleans | France | 45100 | |
74 | Hôpital Saint-Antoine | Paris | France | 75012 | |
75 | Hopital Pitie-Salpetriere | Paris | France | 75013 | |
76 | Hopital Haut-Leveque | Pessac cedex | France | 33600 | |
77 | CHU Purpan Clinique Dieulafoy | Toulouse Cedex | France | 31059 | |
78 | Hôpital de Brabois | Vandoeuvre | France | 54511 | |
79 | UH Charite Berlin / Virchow Klinikum | Berlin | Germany | 13353 | |
80 | Universitätsklinik Düsseldorf | Duesseldorf | Germany | 40255 | |
81 | Center for HIV and Hepatogastroenterology | Düsseldorf | Germany | 40237 | |
82 | UH Essen | Essen | Germany | 45122 | |
83 | Klinikum der Johann Wolfgang Goethe-Universitaet | Frankfurt / Main | Germany | 60590 | |
84 | Albert-Ludwigs-Universitaet Freiburg | Freiburg | Germany | 79106 | |
85 | Medizinische Hochschule Hannover (MHH) | Hannover | Germany | 30623 | |
86 | Universitätsklinikum Heidelberg | Heidelberg | Germany | 69120 | |
87 | Universitätsklinikum Leipzig | Leipzig | Germany | 4103 | |
88 | Johannes Gutenberg-Universitaet Mainz | Mainz | Germany | 55101 | |
89 | Paracelsus Klinik der Stadt Marl | Marl | Germany | 45770 | |
90 | Dayanand Medical College and Hospital | Ludhiana | India | 141001 | |
91 | Jaslok Hospital and Research Centre and Breach Candy Hospital, | Mumbai | India | 400 0026 | |
92 | P. D. Hinduja National Hospital and Medical Research Centre | Mumbai | India | 400 016 | |
93 | G.B.Pant Hospital | New Delhi | India | 110 002 | |
94 | Maulana Azad Medical College and Associated Lok Nayak Hospital | New Delhi | India | 110 002 | |
95 | Bnei-Zion Medical Center | Haifa | Israel | 31048 | |
96 | Rambam Health Care Campus | Haifa | Israel | 31096 | |
97 | Hadassah Medical Organization | Jerusalem | Israel | 91120 | |
98 | Holy Family Hospital | Nazareth | Israel | 16100 | |
99 | Rabin Medical Center Beilinson Campus | Petach Tikva | Israel | 49100 | |
100 | Tel Aviv Sourasky Medical Center | Tel Aviv | Israel | 64239 | |
101 | Bundang CHA Hospital | Bundang | Korea, Republic of | 463-712 | |
102 | Kyungpook National University Hospital | Daegu | Korea, Republic of | 700-721 | |
103 | Pusan National University Hospital | Pusan | Korea, Republic of | 602-739 | |
104 | Seoul National University Hospital(Bundang) | Seonnam City | Korea, Republic of | 463-802 | |
105 | Severance Hospital(SVR) | Seoul | Korea, Republic of | 120-752 | |
106 | Kyunghee University - Medical center | Seoul | Korea, Republic of | 130-702 | |
107 | Samsung Medical Center | Seoul | Korea, Republic of | 135-710 | |
108 | Yongdong Severance Hospital | Seoul | Korea, Republic of | 135-720 | |
109 | Korea University Medical Center(Anam) | Seoul | Korea, Republic of | 136-705 | |
110 | Asan Medical Center | Seoul | Korea, Republic of | 138-736 | |
111 | Korea University Medical Center(Guro) | Seoul | Korea, Republic of | 152-703 | |
112 | Aju University Hospital | Suwon | Korea, Republic of | 443-821 | |
113 | Hospital Alor Setar | Alor Setar | Malaysia | 5150 | |
114 | Hospital Kuala Lumpur | Kuala Lumpur | Malaysia | 50586 | |
115 | University Malaya Medical Centre | Kuala Lumpur | Malaysia | 50603 | |
116 | HUKM | Kuala Lumpur | Malaysia | 56000 | |
117 | Hospital Selayang | Selangor | Malaysia | 68100 | |
118 | Hosp. Universitario. Monterrey | Monterrey N.L. | CP | Mexico | 64460 |
119 | Instituto Nac. de Cs Médicas y Nutrición "Salvador Zubirán" | Mexico | DF | Mexico | 14000 |
120 | Clínica Lomas Altas | Mexico City | Mexico | 11950 | |
121 | Wojewódzki Szpital Specjalistyczny | Bialystok | Poland | 15-540 | |
122 | Niepubliczny Zaklad Opieki Zdrowotnej | Czeladz | Poland | 41-250 | |
123 | Wojewódzki Szpital Zespolony | Kielce | Poland | 25-317 | |
124 | Szpital Uniwersytecki w Krakowie | Krakow | Poland | 31-531 | |
125 | Uniwersytet Medyczny | Lodz | Poland | 91-347 | |
126 | Wojewódzki Szpital Zakaźny | Warszawa | Poland | 01-201 | |
127 | Przychodnia przy Łowieckie | Wroclaw | Poland | 50-220 | |
128 | Fundacion de Investigacion de Diego | Santurce | Puerto Rico | 909 | |
129 | National University Hospital | Singapore | Singapore | 119074 | |
130 | Singapore General Hospital | Singapore | Singapore | 169608 | |
131 | Tan Tock Seng Hospital | Singapore | Singapore | 308433 | |
132 | CGH | Singapore | Singapore | 529889 | |
133 | Hospital Universitari Germans Trias i Pujol | Badalona - Barcelona | Spain | 8916 | |
134 | Hopital Universitari Vall d'Hebron | Barcelona | Spain | 8035 | |
135 | Hospital Clinic i Provincial | Barcelona | Spain | 8036 | |
136 | Hospital Universitario La Princesa | Madrid | Spain | 28006 | |
137 | Hospital General Universitario Gregorio Marañón | Madrid | Spain | 28007 | |
138 | Hospital Carlos III | Madrid | Spain | 28029 | |
139 | Complejo Hospitalario Nuestra Señora de Valme | Sevilla | Spain | 41014 | |
140 | Consorcio Hospital General Universitario de Valencia | Valencia | Spain | 46014 | |
141 | Universitetssjukhuset MAS | Malmö | Sweden | 205 02 | |
142 | Karolinska Universitetssjukhuset | Stockholm | Sweden | 171 76 | |
143 | TCGH-HL | Hualien | R.o.c. | Taiwan | 970 |
144 | KMUH | Kaohsiung | R.o.c. | Taiwan | 807 |
145 | KCGMH | Kaohsiung | R.o.c. | Taiwan | 833 |
146 | VGH-TC | Taichung | R.o.c. | Taiwan | 407 |
147 | NTUH | Taipei | R.o.c. | Taiwan | 100 |
148 | TSGH | Taipei | R.o.c. | Taiwan | 114 |
149 | CGMH-LK | Taoyuan | R.o.c. | Taiwan | 333 |
150 | CCH | Changhua | Taiwan | 500 | |
151 | CMUH | Taichung | Taiwan | 404 | |
152 | NCKUH | Tainan | Taiwan | 704 | |
153 | CMMC | Tainan | Taiwan | 710 | |
154 | TCGH-TP | Taipei | Taiwan | 231 | |
155 | Chulalongkorn Hospital | Bangkok | Thailand | 10330 | |
156 | Ramathibodi Hospital | Bangkok | Thailand | 10400 | |
157 | Siriraj Hospital | Bangkok | Thailand | 10700 | |
158 | Maharaj Nakorn Chiang Mai Hospital, Chiang Mai University | Chiang Mai | Thailand | 50200 | |
159 | Barts and the London NHS Trust | London | United Kingdom | E1 2AT |
Sponsors and Collaborators
- Human Genome Sciences Inc.
- Novartis
Investigators
- Study Director: GSK Clinical Trials, GlaxoSmithKline
Study Documents (Full-Text)
None provided.More Information
Publications
- Bain VG, Kaita KD, Yoshida EM, Swain MG, Heathcote EJ, Neumann AU, Fiscella M, Yu R, Osborn BL, Cronin PW, Freimuth WW, McHutchison JG, Subramanian GM. A phase 2 study to evaluate the antiviral activity, safety, and pharmacokinetics of recombinant human albumin-interferon alfa fusion protein in genotype 1 chronic hepatitis C patients. J Hepatol. 2006 Apr;44(4):671-8. Epub 2006 Jan 30.
- Bain VG, Yoshida EM, Kaita KD, Swain MG, Heathcote EJ, Garcia A, Moore PA, Yu R, McHutchison JG, Subramanian GM. Dynamics of interferon-specific gene expression in peripheral blood of interferon alfa-naïve patients with genotype 1 chronic hepatitis C infection treated with albumin-interferon alfa. Hepatol Res. 2006 Aug;35(4):256-62. Epub 2006 May 30.
- Balan V, Nelson DR, Sulkowski MS, Everson GT, Lambiase LR, Wiesner RH, Dickson RC, Post AB, Redfield RR, Davis GL, Neumann AU, Osborn BL, Freimuth WW, Subramanian GM. A Phase I/II study evaluating escalating doses of recombinant human albumin-interferon-alpha fusion protein in chronic hepatitis C patients who have failed previous interferon-alpha-based therapy. Antivir Ther. 2006;11(1):35-45.
- S. Zeuzem, , Y. Benhamou, , D. Shouval, , V. Bain, S. Pianko, , R. Flisiak, , M. Grigorescu, , V. Rehak, , E. Yoshida, K. Kaita, , C. Hezode, A.U. Neumann, M. Subramanian, J. McHutchison. Interim (Week 12) Phase 2B Virological Efficacy and Safety Results of albumin interferon alfa-2b Combined with Ribavirin in Genotype 1 Chronic Hepatitis C Infection. EASL, 2006
- Vinod Rustgi, et al. A Dose-Escalation Study of albumin alfa-Ribavirin in Non-responders to Prior Interferon Based Therapy for Chronic Hepatitis C Infection Phase 2 Dose A Phase 2 Dose-Escalation Study of albumin interferon alfa interferon alfa-2b Combined with 2b Combined with Ribavirin in Non Non-responders to Prior Interferon. EASL, 2006
- HGS1008-C1067
- ACHIEVE-2/3